So this really was profound news, not a doubt. Thi
Post# of 5066
Quote:
... but this provides additional trade secrets in our production methodology with the possibility of filing new patents on the optimized methodology and reagents we have developed."
So this seems to be the blood taken from the human host/patient. the reagent is the genetic modification done making the new blood "cocktail".
then eventually injected back into host,
with the later not done yet. Is this what has happened so far?
Is it this process and mixture that will require new patents BEFORE a complete IND is submitted to FDA?
Is this process taking place at Benitec? or do we know this yet?